PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68)Ga‐PSMA‐11 PET Using Cyclotron‐Produced (68)Ga

Prostate‐specific membrane antigen (PSMA) is a validated target for molecular diagnostics and targeted radionuclide therapy. Our purpose was to evaluate PSMA expression in hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and hepatic adenoma (HCA); investigate the genetic pathways in HCC ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Scott M., Suman, Garima, Torbenson, Michael S., Chen, Zong‐Ming E., Jondal, Danielle E., Patra, Anurima, Ehman, Eric C., Andrews, James C., Fleming, Chad J., Welch, Brian T., Kurup, Anil N., Roberts, Lewis R., Watt, Kymberly D., Truty, Mark J., Cleary, Sean P., Smoot, Rory L., Heimbach, Julie K., Tran, Nguyen H., Mahipal, Amit, Yin, Jun, Zemla, Tyler, Wang, Chen, Fogarty, Zachary, Jacobson, Mark, Kemp, Bradley J., Venkatesh, Sudhakar K., Johnson, Geoffrey B., Woodrum, David A., Goenka, Ajit H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035563/
https://www.ncbi.nlm.nih.gov/pubmed/34783177
http://dx.doi.org/10.1002/hep4.1861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035563/
https://www.ncbi.nlm.nih.gov/pubmed/34783177
http://dx.doi.org/10.1002/hep4.1861

Ejemplares similares